home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Biotech Jounce Therapeutics files for a $75 million IPO
Biotech Jounce Therapeutics files for a $75 million IPO
Post navigation
Previous Post
Previous
Blueprint Medicines Announces Pricing of Public Offering of Shares of Common Stock
Next Post
Next
Blueprint Medicines to Report Fourth Quarter and Full Year 2016 Financial Results on Thursday, March 9, 2017